AEVA
Aeva Technologies, Inc.
There isn't enough reported data to score AEVA yet.
AMZN
Amazon.com, Inc.
AMZN's fundamentals are mixed: revenue grew 15%, but free cash flow turned negative. Its PE of 22x looks cheaper than it really is, because one-off gains boosted its recent earnings. Analysts expect strong earnings growth.
AEVA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Unavailable |
AEVA's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
AEVA PE Valuation
AEVA has no meaningful PE right now: it lost money over the past year.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
AEVA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect AEVA's losses to shrink, with revenue growing.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
AEVA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.74 | +$2.57 |
| Q2 2026 | -$2.72 | +$2.77 |
| Q1 2026 | -$4.98 | -$2.16 |
| Q4 2025 | -$5.06 | -$2.21 |
| Q3 2025 | -$5.31 | -$2.17 |
| Q2 2025 | -$5.49 | -$2.30 |
| Q1 2025 | -$2.82 | +$0.35 |
| Q4 2024 | -$2.85 | +$0.45 |
AEVA is still losing money, but far less than before: $2.74 per share over the past year, against $5.49 at its worst in mid-2025.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over AEVA on earnings quality, reporting a profit while its opponent remains loss making.
AEVA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.7M | +86% |
| Q2 2026 | $6.1M | +11% |
| Q1 2026 | $6.3M | +86% |
| Q4 2025 | $5.6M | +108% |
| Q3 2025 | $3.6M | +59% |
| Q2 2025 | $5.5M | +174% |
| Q1 2025 | $3.4M | +60% |
| Q4 2024 | $2.7M | +67% |
AEVA has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -586% | +340 points |
| Q2 2026 | -563% | +71 points |
| Q1 2026 | -561% | +342 points |
| Q4 2025 | -518% | +752 points |
| Q3 2025 | -927% | +757 points |
| Q2 2025 | -634% | +1797 points |
| Q1 2025 | -903% | +869 points |
| Q4 2024 | -1270% | +1017 points |
AEVA's operating margin was −586% last quarter, up 340 points from the same quarter a year ago.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over AEVA on profitability, with a higher operating margin.
AEVA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$30.6M | +$3M |
| Q2 2026 | -$31.4M | -$162K |
| Q1 2026 | -$28.1M | +$3.2M |
| Q4 2025 | -$23.7M | -$623K |
| Q3 2025 | -$33.6M | -$7.2M |
| Q2 2025 | -$31.2M | -$1.2M |
| Q1 2025 | -$31.3M | +$1.4M |
| Q4 2024 | -$23M | +$7M |
AEVA has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
AEVA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +11% | +7.1M shares |
| 1 year | +18% | +10.7M shares |
| 3 years | +61% | +27.2M shares |
| 5 years | +69% | +29.3M shares |
AEVA has 72M diluted shares, up 18% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over AEVA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
AEVA Net Leverage
AEVA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
AEVA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 12.2 | Oversold |
AEVA's weekly RSI is 43 (neutral) and its Stochastic is 12 (oversold).
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
AEVA PE vs Consumer Cyclical Sector
AEVA has no meaningful PE right now: it lost money over the past year.
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
AEVA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.0 | 1.7% below |
| 20 week MA | $16.0 | 26% below |
| 50 week MA | $16.5 | 28% below |
| 100 week MA | $14.7 | 20% below |
| 200 week MA | $9.65 | 22% above |
AEVA has fallen below most of its moving averages, though it's still 22% above its 200-week average.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over AEVA on trend strength, trading above more of its moving averages.
AEVA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $49.3 | $88.8 | +80% |
| 2021 | $88.8 | $41.9 | -53% |
| 2022 | $41.9 | $6.35 | -85% |
| 2023 | $6.35 | $3.79 | -40% |
| 2024 | $3.79 | $4.77 | +26% |
| 2025 | $4.77 | $13.2 | +177% |
| 2026 YTD | $13.2 | $11.8 | -11% |
AEVA's yearly returns have swung widely, from +177% in 2025 to −85% in 2022. It's down 11% so far in 2026.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over AEVA on returns for 2026, with the stronger performance.